Medicine of the Future in America

Tag Archives: acute pulmonary embolism

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (12)

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (12)Among the excluded patients, the most common situation was a “low probability of PE” V/Q scan interpretation and low clinical suspicion for PE. Another shortcoming of this study is a limited experience in applying the FPA assay designed for plasma to urine testing. One investigation suggests that urine contains significant amount of carboxyterminally degraded FPA, which may be undetected by assays that contain antibody directed mostly against the carboxyterminal. This reduced sensitivity may cause spuriously low values, and some patients with elevated plasma FPA may have normal urine FPA. The assay used in this study identified all patients who had PE; therefore, there who was no clinical evidence that the study assay suffers from reduced sensitivity. In addition, it is known that antibodies that cross-react with canine FPA are directed against the carboxyterminal portion of the peptide. The antibody used in our assay has no significant cross-reactivity with canine FPA, thus providing a strong evidence that it is directed against the amino terminal. buy flovent inhaler
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (11)

Conversely, an obstructed or severely reduced blood flow to a pulmonary segment can be caused by focal parenchymal disease or an embolism other than a venous thrombosis. In these instances, the uFPA would be normal; however, V/Q scans may be suggestive of PE. Indeed, there is one patient in this study who had a “high probability of PE” V/Q scan interpretation and normal uFPA concentration (Fig 1). A PA study done within a few hours after V/Q scan was negative for PE. Two other patients had a “moderate probability of PE” V/Q scan pattern, a test result that neither makes nor excludes the diagnosis of PE. These two patients were referred for PA studies (as commonly occurs under such circumstances), which were negative, as were the uFPA tests. Consequently, by using the combination of uFPA and V/Q scans, PE may be excluded noninvasively in more patients than by using either test alone, and, therefore, the need for performing PA may be reduced. antibiotics levaquin
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (10)

Therefore, it is generally agreed that although elevated levels of pFPA or uFPA are not specific for PE, the normal test indicates that the likelihood of PE is very low. ampicillin antibiotic
Although pFPA levels can be useful in excluding PE in suspected patients, the clinical utility of the test has been hampered by the following factors: (1) a blood sample must be carefully obtained by experienced personnel using an atraumatic technique; and (2) the assays available for determination of pFPA were complicated and time-consuming. Recently, an enzyme-linked immunoassay was developed that expedites and simplifies measurement of FPA (Assera-chrom FPA). Another simplification became possible with the demonstration that there was a close correlation of plasma FPA concentration with FPA concentration measurement in a random urine sample. These developments allow convenient and accurate estimation of FPA generation in clinical practice.
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (9)

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (9)All the patients in that study were examined within the first 24 h after the onset of symptoms. In another study, only two of 18 patients with PE had a normal pFPA level; however, both patients were examined more than five days after the onset of symptoms. These findings suggest that FPA generation may normalize in patients examined more than 24 h after the onset of symptoms. Furthermore, the inverse relationship of symptom duration (time elapsed between the onset of symptoms and the examination) and the pFPA concentration was elegantly demonstrated by Yudelman et al. All of the patients with PE whose cases were reported in this study were examined within 24 h after the onset of symptoms. ventolin 100 mcg

Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (8)

Discussion
Currently, V/Q scan is the mainstay in evaluation of patients with suspected PE and frequently is the initial diagnostic procedure that has a major impact on patient treatment. A normal perfusion lung scan virtually excludes PE. On the other hand, the “high probability of PE” V/Q scan in patients with a compatible clinical presentation is accepted widely as sufficient evidence of PE. However, a significant number of patients have equivocal V/Q scan findings and require additional invasive testing. Therefore, a rapid blood or urine test, which could reliably exclude PE, would be very helpful as an initial screening test. Multiple tests have been tried for this purpose, but most were found to be either diagnostically useless or clinically impractical, while others are still debated. A recent comprehensive review of this subject concluded that at the present time, only normal plasma concentration of FPA and fragment E may be helpful in excluding venous thrombosis or thromboembolism. Buy Advair Diskus Online
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (7)

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (7)The times between the onset of symptoms and uFPA testing were significantly (p = 0.025) shorter in patients with PE (13 h, range 6 to 24 h) than those without PE (27.6 h, range 8 to 72 h).
PE was diagnosed by PA in four patients and by the V/Q scan criteria in three patients. PE was excluded by a normal V/Q scan in 16 patients and by negative PA in six patients. Individual patients results are presented in Figure 1. birth control yasmin
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (6)

Statistical Analyses
As noted previously by others, the frequency distribution of FPA is log-normal. Therefore, logarithmic transformation was performed to obtain a normal, ie, gaussian, frequency distribution. The differences between the groups were then tested by the modified t test and a p value of less than 0.05 was considered significant. Thus, the uFPA data are in the form of their geometric means ± the geometric standard deviation (SD). Other data are expressed as the arithmetic means and SD. These data were analyzed using an unpaired t test. The true negative rate of the test was defined as the percentage of patients in whom PE was excluded who had a negative test result. Cheap Diskus Advair
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (5)

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (5)The urine samples were collected and 3-ml aliquots were transferred to special tubes containing 0.75 ml of an aqueous anticoagulant solution. The anticoagulant solution contained the following (all values are final concentrations): sodium azide, 0.2 mg/ml; sodium citrate, 22 mmol; porcine interstitial heparin (Sigma H7005), 200 U/ml; and aprotonin (Sigma A-1153), 0.2 trypsin inhibitory units (TIU)/ml. All the samples were frozen within 20 min of collection at — 70°C. buy cheap antibiotics
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (4)

“Moderate probability of PE”: (1) Normal chest roentgenogram, normal ventilation study, and several subsegmental perfusion defects the sum of which is equivalent to two segments. (2) Severe chronic obstructive airways disease, no opacification on the chest roentgenogram, and matched or partially unmatched perfusion defects. (3) Opacification of the chest roentgenogram and nonsegmental perfusion defect that is approximately equal in size to the area of the roentgenogram opacification. proventil inhaler
Continue reading

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (3)

Urinary Fibrinopeptide A in Evaluation of Patients with Suspected Acute Pulmonary Embolism (3)Patients Excluded from Analysis
Patients with conditions known to alter FPA levels (those who had undergone surgery within four days and those receiving anticoagulation therapy) were excluded from the final analyses. Patients who had an abnormal perfusion scan but did not undergo PA were excluded, except for those who fulfilled diagnostic criterion 2. buy birth control online
V/Q Lung Scan and Pulmonary Angiography
A detailed description of the technique and interpretation of V/Q lung scan at our institution has been published previously. Briefly, ventilation studies were performed with 20 mCi of Xe-133 gas, and single-breath, equilibrium, and wash-out images were obtained in the posterior projection immediately before the perfusion study. If a perfusion defect was not seen adequately in the posterior view, a ventilation study was repeated in the view that allowed the best visualization of the perfusion defect. Three millicuries of Tc-99m labeled macroaggregated albumin was used to obtain multiple perfusion images. The scans were interpreted according to the following criteria:
Continue reading

Copyright © 2012 Medicine of the Future in America www.perfexis.org